HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiolipomas: an ultrastructural and clinicopathological study.

Abstract
The clinicopathologic features of 50 noninfiltrating angiolipomas are presented, with a detailed ultrastructural study of five cases and immunoflourescence study of one case. The clinical presentation, including age, location, and associated symptoms, is discussed. Pertinent light microscopic findings, including features helpful in diagnosing borderline lesions, are described. The first ultrastructural and immunofluorescence study of this entity is presented. Among various ultrastructural findings, there appear to be decreased numbers of Weibel-Palade bodies in the endothelial cells of all angiolipomas studied. The relationship of Weibel-Palade bodies to the functional state of the cell and their possible procoagulative effect are discussed. Immunofluorescence and ultrastructural studies further suggest that endothelial disruption and endothelial fibrinogen contribute to the fibrin thrombus formation typically found in angiolipomas.
AuthorsA Y Dixon, D H McGregor, S H Lee
JournalHuman pathology (Hum Pathol) Vol. 12 Issue 8 Pg. 739-47 (Aug 1981) ISSN: 0046-8177 [Print] United States
PMID7026412 (Publication Type: Journal Article)
Chemical References
  • Fibrin
Topics
  • Adipose Tissue (pathology, ultrastructure)
  • Adult
  • Aged
  • Blood Coagulation
  • Blood Vessels (pathology)
  • Capillaries (ultrastructure)
  • Cytoplasm (ultrastructure)
  • Endothelium (cytology)
  • Fibrin (immunology)
  • Fluorescent Antibody Technique
  • Hemangioma (diagnosis, pathology, ultrastructure)
  • Humans
  • Lipoma (diagnosis, pathology, ultrastructure)
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: